AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

European Medical Solutions

AGM Information Jun 19, 2018

3942_rns_2018-06-19_8597fe4d-cc28-41b7-958a-8fbbfe6a84b6.pdf

AGM Information

Open in Viewer

Opens in native device viewer

ENGLISH TRANSLA TION FOR INFORMA TION PURPOSE

ASIT BIOTECH LIMITED LIABILITY COMPANY HAVING MADE A PUBLIC APPEAL ON SAVTNGS Avenue Ariane 5 1200 Brusscls LER Brussels 0460.798.795 (the Company)

MINUTES OF THE ANNUAL GENERAL SIIAREHOLDERS' MEETING

14 JUNE 2018

I. Opening ofthe meeting

The Annual General Meeting was held on 14 June 2018 at the registered office of SA ASIT biotech.

The session was opened at 3pm under the presidency of Mr Everard van der Straten, Chairman of the Board of Directors.

IL Office

Composition ofthe office

The Chairman appointed Mr Adrien Lanotte as Secretary ofthe General Meeting.

The Chairman appointed Mr Grégory Nihon and Mr Albert Vicaire as scrutineers.

The composition ofthe office was accepted by the General Meeting.

Checks performed by the office

The Chairman reported to the General Meeting on the observations and checks performed by the office with respect to the composition of the General Meeting in the course of and after completion of the registration procedure ofthe participants:

(i) Convocations

The convening notices containing the agenda of the General Meeting hâve been publishcd within the delays foreseen by the articles of association and article 533 and following of the Companies Code. Before the opening of the General Meeting, the proof of publication of the convening notices in the Belgian State Gazette and in the financial press were presented to the office. The Chairman brought to the attention of the Meeting and the office noted that on 15 May 2018 the convening notice lias been published in l'Echo and on 15 May 2018 in the Belgian State Gazette and that the text ofthe agenda, the convening notices and the proxy templates and other documents required by law (i.e. under the articles 533bis and following and 553 ofthe Companies Code) hâve been published on the Company's website as from 15 May 2018.

With a view to equally assure the international spread, a communication lias amongst others been sent

ENGLISH TRANS LA TION FOR INFORMA TION PURPOSE

by a press agency.

The office further also noted that a convening notice lias on 15 May 2018 equally been sent by mail or email to the registered shareholders, the holders ofwarrants and statutory auditors. The same letter lias been sent to the directors in the manner agreed upon with them. A copy ofthe convening notice will be held by the Company.

The office notes that the following documents hâve been addressed to the registered shareholders and hâve been made available on the Company's website on 15 May 2018:

  • The invitation to the general shareholders' meeting;
  • The proxy form;
  • A notice resuming the righls ofthe shareholders;
  • The amiual financial statements;
  • The management report ofthe board of directors;
  • The animal report including the amiual Consolidated accounts;
  • The statutory auditor's report on the annual financial statements;
  • The statutory audilor's report on the Consolidated financial statements;
  • The draft of warrant's plan 2018;
  • The Curriculum Vitae ofMr Harry Welten.
  • (ii) Vérification ofthe credentials ofthe participants

To assist to the Ordinary General Meeting, the shareholders présent or represented hâve timely fulfilled the formalitics required by law or the articles of association. The lists hâve been transferred to the office for vérification and will be conserved.

(iii) Attendance list

As results ffoni the attendance list, the shareholders présent or represented, which hâve fulfilled the legal and statutory formalitics, represent 9,165,147 sliares each giving right to one vote (i.e. a présence of 55.63 % on a total of 16,473,972 issued shares). The présent general meeting can validly deliberate regardless ofthe number ofshares represented and the majority of votes.

The présent General Meeting is validly composed and can validly deliberate and vote on the items on the agenda.

ni. Agenda

The meeting relieved the Chairman oflus obligation to read the items on the agenda, which were as follows:

1. Présentation ofthe annual report oftlie Board of directors

ENGLISH TRANSLA TION FOR INFORMA TIONPURPOSE

The rémunération report of the Board of directors as includcd in the animal report

Proposée! resolution: approval of the rémunération report ofthe Board of directors, as explained by the nomination and rémunération committee and as included in the annual report.

Présentation of the report ofthe auditors committee on the financial year ended 31 December 2017

Acknowledgement ofthe content ofthe Consolidated financial statements

Approval ofthe statutory accounts relating to the financial year ended 31 December 2017 - Allocation of results

Proposée! resolution: approval of the statutory accounts in relation to the financial year ended 31 December 2017, including the proposed carrying-forward ofthe losses to be carried forward.

Discharge to be granted to the directors for the financial year ended 31 December 2017

Proposée! résolution: granting, by spécial vote, discharge to eacli director for the exercise of its respective mandate during the financial year ended 31 December 2017.

Discharge to be granted to the auditors for tlic financial year ended 31 December 2017

Proposée!resolution: granting, by spécial vote, discharge to each auditor for the exercise of its respective mandate during the financial year ended 31 December 2017.

Appointment of director

Proposed résolution: f/pon proposai of the nomination and rémunération committee, to appoint as director Harry Welten for a terni of 4 years, ending on the annual shareholders' meeting of 2022 that will approve the financial statements ofthe financial year ended 31 December 2021.

The information regarding the compétences and the expérience of the Board nominee is enclosed to this notice.

Approval ofthe Warrant Plan 2018 and, in particular, of the "change of control" clause included in the Warrant Plan 2018 with respect with the article 556 ofthe Company Code

Proposed résolution: approval ofthe Warrant Plan 2018 allowing the grant in 2018 ofwarrants for the benefit of employées, consultants, managers, executive and non-executive directors ofthe Company to be identified by the Board of directors upon the proposai of the nomination and rémunération committee, with a vesting period ofthree years and where the exercise price will be the lowcsl price between (i) the average closing price during the 30 days preceding the date of the offer (ii) the last closing price preceding the date ofthe offer. More specifically, approve, in accordance with article 556 of the Company Code, the anticipated exercise clause in case of change of control or takeover bid on the Company's shares.

Renewal of auditor's mandate

Proposed résolution: approval the renewal of Mazars Reviseurs d'Entreprises SCRL (B00021) represented by Xavier Doyen as statutory auditor for a period of 3 years, ie until the ordinary meeting of2021. The annual rémunération is fixed at 25,000 euros excluding VAT, to be divided equally among the members ofthe College ofAuditors.

ENGLISH TRANSLATION FOR INFORMA TION PURPOSE

11. Proxy

Proposée! résolution: Grant a power of attorney to Grégory Nihon and/or Adrien Lanottc (CMS Bclgium), each with authorization to act on his own and vvith power to sub-delegate, to give effect or implement ail the above-adopted resolutions, including the filling and the publication in the annexes to the Belgian Official Gazette.

IV. Deliberations

The Chairman broaches the agenda. Upon the Chairman's proposai, the General Meeting dispenses the office from reading the reports provided for under items 2 and 3 in the agenda, the latter ones having been made available to each of the shareholders and having been addressed to the registered shareholders who could therefore become acquainted with it before the meeting.

1. Présentation ofthe annual report ofthe Board of directors

Mr van der Straten and Mr Legon begin to review the activities and results ofthe Company for the year 2017 as well as an overview oftrends for 2018.

2. The rémunération report ofthe Board of directors as includcd in the annual report

Mr van der Straten, upon approval from the Chairman of the Nomination and Rémunération Conunittee présents and comments the Rémunération Report.

After deliberation, the Meeting décidés to approve the Rémunération Report from the Board of Directors, as presented by the Nomination and Rémunération Conunittee and as set out under the Annual Report.

In favour 8,670,229
Against 494,918
Abstention 0

3. Présentation of the report of the auditors committce on the financial year ended 31 December 2017

The General Meeting does not comment on the report ofthe auditors conunittee on the financial year ended 31 December 2017.

4. Acknowledgement of the content of the Consolidated financial statements

The General Meeting does not comment on the content ofthe Consolidated financial statements.

5. Approval of the statutory accounts relating to the financial year ended 31 December 2017 - Allocation of results

The Chairman provides the General Meeting with the annual accounts ofthe Company for the financial year ended 31 December 2017 as well as the project of allocation ofresults.

ENGLISH TRANSLA TION FOR INFORMA TION PURPOSE

The results of the financial year resulted in a loss of 13,080,748 EUR. The Board of Directors proposes to carry the loss forward, which would amount to a total loss carried forward (taking into account the 21,427,223 EUR losses from previous financial years and déduction from subscribed capital of 7,517,227 EUR in 2017) of 26,990,744 EUR.

After deliberation, the Meeting décidés to approve the statutory accounts relating to the financial year ended 31 December 2017 including the proposed loss carry forward.

In favour 9,165,147
Against 0
Abstention 0

6. Discharge to be granted to the directors for the financial year ended 31 December 2017

The General Meeting décidés to grant discharge to eacli ofthe directors identified hereunder in respect ofthe exercise oftheir respective mandate during the financial year ended 31 December 2017:

  • Béatrice De Vos ;
  • Thierry Legon ;
  • Jean Duchateau ;
  • François Meurgey;
  • Everard van der Straten ;
  • Gerd Zettlmeissl ;
  • Meusinvest SA represented by Marc Foidart ;
  • Bruservices SA represented by Henri De Meyer;
  • RE Finance Consulting SA represented by Yves Désirant;
  • SFPI SA represented by François Fontaine.
In favour 9,165,147
Against 0
Abstention 0

7. Discharge to be granted to the auditors for the financial year ended 31 December 2017

The General Meeting décidés to grand discharge to eacli of the Auditors, Mazars Réviseurs d'Entreprises SCRL represented by Xavier Doyen and RSM Réviseurs d'Entreprises SCRL represented by Luis Laperai, for the exercise oftheir respective mandate during the financial year ended 31 December 2017.

In favour 9,165,147
Against 0
Abstention 0

8. Appointment of directors

The General Meeting approve the renewal ofMazars Reviseurs d'Entreprises SCRL (B00021) represented by Xavier Doyen as statutory auditor for a period of 3 years, ie until the ordinary meeting of 2021. The annual rémunération is fixed at 25,000 euros excluding VAT, to be divided equally among the members ofthe College ofAuditors.

The information regarding the compétences and the expérience ofthe Board nominec is cncloscd to this notice.

In favour 9,165,147
Against 0
Abstention 0

ENGLISH TRANSLA TION FOR INFORMATION PURPOSE

9. Approval of thc Warrant Plan 2018 and, in particular, of the "change of control" clause included in the Warrant Plan 2018 vvith respect with the article 556 of the Company Code

The General Meeting approve Warrant Plan 2018 allowing the grant in 2018 of warrants for the benefit of employées, consultants, managers, executive and non-executive directors of the Company to be identified by the Board of directors upon the proposai of the nomination and rémunération committee, with a vesting period of three years and where the exercise price will be the lowest price between (i) the average closing price during the 30 days preceding the date of the offer (ii) the last closing price preceding the date of the offer. More specifically, approve, in accordance with article 556 of the Company Code, the anticipated exercise clause in case of change of control or takeover bid on the Company's shares.

In favour 5,096,452
Against 1,195,026
Abstention 2,873,669

10. Renewal of auditor's mandate

The General Meeting approve the renewal of Mazars Reviseurs d'Entreprises SCRL (B00021) represented by Xavier Doyen as statutory auditor for a period of 3 years, ie until the ordinary meeting of 2021. The annual rémunération is fixed at 25,000 euros excluding VAT, to be divided equally among the members ofthe College ofAuditors.

In favour 9,165,147
Against 0
Abstention 0

11. Proxy

The General Meeting décidés to grant a power of attorney to Grégory Nihon and/or Adrien Lanotte (CMS Belgium), each with authorization to act on his own and with power to sub-delegate, to give effect or implement ail the above-adopted resolutions, including the filling and the publication in the annexes to the Belgian Official Gazette.

In favour 9,165,147
Against 0
Abstention 0

As ail items on the agenda ofthe General Meeting hâve bcen discussed, the Chairman requests the Meeting, which acccpls, to dispense the Secretary to read the présent minutes, which faithfully reflect the content ofthe discussions. The présent minutes hâve been prepared in French (with a frec translation in English, only for information purposes) and lias been signed by the members of the office, the directors présent and the shareholders or their représentatives who equally wished to sign.

The Chairman closes the présent Annual General Meeting.

The meeting is closcd at 4 pm.

Brussels, 14Junc2018.

ENGLISH TRANSLA TION FOR INFORMA TION PURPOSE

Talk to a Data Expert

Have a question? We'll get back to you promptly.